Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Earnings Per Share

Annual EPS

-$12.85$9.05+41.33%

Summary

Current Value
As of today, MDGL annual EPS is -$12.85, up +41.33% on
Historical Performance
MDGL annual EPS is up +25.44% over the past 3 years, up +1.86% over the past 5 years
All-Time High Comparison
MDGL annual EPS is currently -115.83% below its historical high of $81.20 set on
3-Year Low Comparison
MDGL annual EPS is +41.33% above its 3-year low of -$21.90 reached on
Sector Comparison
MDGL annual EPS is higher than 13.37% of companies in Healthcare sector
Analyst Estimate
Analysts estimate MDGL annual EPS at -$5.73, +55.43% higher than the current value
Upcoming Earnings
As of today, the next annual earnings release for MDGL has not been scheduled

EPS Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual EPS-$12.85+41.3%+25.4%+1.9%+60.5%
Quarterly EPS-$2.57+5.3%+48.5%+32.8%+65.1%
TTM EPS-$12.86+41.8%+25.3%+1.7%+60.0%
Price$424.98+24.5%+55.8%+271.6%+139.5%
Annual Revenue$958.40M+432.1%+100.0%+100.0%+6374.4%
PE Ratio-
Annual Net Income-$288.28M+38.1%+2.4%-42.5%-669.4%
Annual Gross Profit$900.75M+421.3%+10000.0%+10000.0%+100.0%
Shares Outstanding22.71M+2.9%+25.2%+41.7%

EPS Highs

MDGL Annual EPS Highs Comparison
PeriodHighDateCurrent
3Y-$12.85at high
5Y-$12.85at high
All$81.20-115.8%

EPS Lows

MDGL Annual EPS Lows Comparison
PeriodLowDateCurrent
3Y-$21.90+41.3%
5Y-$21.90+41.3%
All-$1,401.05+99.1%

EPS Estimates

MDGL EPS Estimates reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$23.47-$21.90+6.69%
-$11.43-$12.85-12.39%
-$5.73N/A+55.43%
$14.14N/A+210.01%
MDGL EPS Estimates reported versus estimate values chart

🔒 Log In To Unlock Full Data

EPS History

YearValueChange
-$12.85+41.3%
-$21.90-9.5%
-$19.99-16.0%
-$17.23-17.8%
-$14.63-11.7%
-$13.09-140.1%
-$5.45-145.9%
-$2.22+12.7%
-$2.54+49.9%
-$5.07+99.6%
-$1,401.05-4,501.1%
-$30.45+31.5%
-$44.45-19.8%
YearValueChange
-$37.10-6.0%
-$35.00-7.5%
-$32.55-140.1%
$81.20+184.4%
-$96.25+26.9%
-$131.60-41.4%
-$93.10+13.9%
-$108.15-25.6%
-$86.10-32.3%
-$65.10+57.4%
-$152.95-3,261.5%
-$4.55-

FAQ

  • What is the current annual EPS of MDGL?

    As of today, MDGL annual EPS is -$12.85

  • What is 1-year change in MDGL annual EPS?

    MDGL annual EPS is up +41.33% year-over-year

  • What is 3-year change in MDGL annual EPS?

    MDGL annual EPS is up +25.44% over the past 3 years

  • How far is MDGL annual EPS from its all-time high?

    MDGL annual EPS is currently -115.83% below its historical high of $81.20 set on December 31, 2009

  • How does MDGL annual EPS rank versus sector peers?

    MDGL annual EPS is higher than 13.37% of companies in Healthcare sector

  • How does the analyst estimate for MDGL annual EPS compare to its current value?

    Analysts estimate MDGL annual EPS at -$5.73, +55.43% higher than the current value

  • When is MDGL next annual earnings release?

    As of today, the next annual earnings release for MDGL has not been scheduled

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl